The Mt. Sinai study could open the door to future therapies for Alzheimer’s, amyotrophic lateral sclerosis, brain cancer, and drug addiction.

Researchers at the University of Virginia have created the first comprehensive protein-level atlas of brain development, ...

Scientists have developed a lipid nanoparticle system capable of delivering messenger RNA (mRNA) to the brain via intravenous injection, a challenge that has long been limited by the protective nature ...

Scientists at the Icahn School of Medicine at Mount Sinai have developed a lipid nanoparticle system capable of delivering ...

Medications are the mainstay of treatment for multiple sclerosis (MS). Many of them are used to block the immune system's attack on the nerves and slow or prevent progression and relapses (flare-ups) ...

The main differential diagnoses include osteoblastic metastases, tuberous sclerosis, and renal osteodystrophy, requiring careful differentiation because of their similarities. Sclerosing bone ...

Multiple sclerosis (MS) is one of the most widespread ... nerve fibers, and neurons in the brain and spinal cord. Together these make up the central nervous system. Researchers speculate that ...

Bone Science has launched Prime Brain, a fourth-generation supplement designed to support cognitive function, academic focus, and stress management in children and adolescents through a scientifically ...

The study was published in the journal Nature Communications. The drug, LL-341070, enhances the brain's ability to repair damaged myelin— the protective sheath around nerve fibers. Damage to ...

Certain types of cereal can potentially increase the amount of gray matter in the brain and enhance cognition ... role in protecting our muscles and bone mass as we age, thus reducing the risk ...

Multiple sclerosis (MS), a chronic inflammatory and degenerative autoimmune ... Recent research on cellular and molecular features of bone marrow hematopoietic cells in treatment-naïve MS indicated ...

A significant portion of patients with multiple sclerosis (MS) can achieve a stable ... Study criteria at baseline included no changes in patient brain lesions on MRI for at least 3 years and ...